Omvoh 100 mg

Omvoh 100 mg is a medicine authorised by Swissmedic under authorisation number 68952. The authorisation holder is Eli Lilly (Suisse) SA. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 30 November 2023 and the authorisation is limited until 29 November 2028. ATC code L04AC24 places the medicine in the group Immunosuppressants.

  • Dispensing category B
  • Authorisation number 68952
  • ATC L04AC24
  • Biotechnological medicines
Authorisation data
Authorisation number68952
NameOmvoh 100 mg
Full nameOmvoh 100 mg, solution injectable en stylo prérempli
Authorisation holderEli Lilly (Suisse) SA
Medicinal product codeBiotechnological medicines
Dispensing categoryB · Prescription only
ATC codeL04AC24
First authorisation30 November 2023
Authorisation validity29 November 2028
Strengths
No.NameDispensing categoryAuthorisation date
1Omvoh 100 mg, solution injectable en stylo prérempliB30 November 2023
2Omvoh 100 mg + 200 mg, solution injectable en stylo prérempliB20 June 2025
3Omvoh 200 mg, solution injectable en stylo prérempliB27 February 2026

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
12Injektor(en), vorgefüllt/PenL04AC2407.15.0.B
21 + 1Injektor(en), vorgefüllt/PenL04AC2407.15.0.B
31Injektor(en), vorgefüllt/PenL04AC2407.15.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Omvoh 100 mg authorised in Switzerland?

Yes. Omvoh 100 mg is authorised by Swissmedic under authorisation number 68952, data as of 01 September 2026. The authorisation is limited until 29 November 2028.

Which dispensing category does Omvoh 100 mg have?

Omvoh 100 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Omvoh 100 mg?

The authorisation holder is Eli Lilly (Suisse) SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com